Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin

ABSTRACT We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Raf. One gene identified in these analyses encodes for α-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of ras, but high in transformation-impaired, derivative cell lines in which the mutant ras allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.

[1]  C. Der,et al.  Loss of Transgelin in Breast and Colon Tumors and in RIE-1 Cells by Ras Deregulation of Gene Expression through Raf-independent Pathways* , 2002, The Journal of Biological Chemistry.

[2]  C. Der,et al.  Oncogenic Ras Blocks Anoikis by Activation of a Novel Effector Pathway Independent of Phosphatidylinositol 3-Kinase , 2001, Molecular and Cellular Biology.

[3]  J. Herman,et al.  DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.

[4]  A. Schulze,et al.  Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.

[5]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[6]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[7]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hong Zhang,et al.  NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis , 2000, Oncogene.

[9]  M. Szyf,et al.  Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. , 2000, Gene.

[10]  C. Der,et al.  Involvement of NH2-terminal Sequences in the Negative Regulation of Vav Signaling and Transforming Activity* , 1999, The Journal of Biological Chemistry.

[11]  E. Li,et al.  Cloning, expression and chromosome locations of the human DNMT3 gene family. , 1999, Gene.

[12]  Y. Fu,et al.  Association of K-ras mutations with p16 methylation in human colon cancer. , 1999, Gastroenterology.

[13]  R. Friedman,et al.  Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene , 1999, Molecular and Cellular Biochemistry.

[14]  J. Tschopp,et al.  Oncogenic Ras inhibits Fas ligand‐mediated apoptosis by downregulating the expression of Fas , 1999, The EMBO journal.

[15]  N. Harindranath,et al.  Suppression of src-induced transformed phenotype by expression of tropomyosin-1 , 1999, Oncogene.

[16]  E. Jonasch,et al.  Ras- and Raf-induced Down-modulation of Non-muscle Tropomyosin Are MEK-independent* , 1998, The Journal of Biological Chemistry.

[17]  Channing J Der,et al.  Rho family proteins and Ras transformation: the RHOad less traveled gets congested , 1998, Oncogene.

[18]  R. Braverman,et al.  Suppression of Neoplastic Transformation and Regulation of Cytoskeleton by Tropomyosins , 1998, Somatic cell and molecular genetics.

[19]  G. Auer,et al.  Down-regulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK1-dependent autocrine loop. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  S. Oldham,et al.  Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade , 1998, Oncogene.

[21]  R. Hurst,et al.  G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. , 1998, Journal of cellular biochemistry. Supplement.

[22]  L. Secker-Walker,et al.  General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997 , 1998, Leukemia.

[23]  M. White,et al.  Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.

[24]  D. Bar-Sagi,et al.  Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. , 1998, Science.

[25]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[26]  G. Auer,et al.  Phenotypic analysis of ovarian carcinoma: Polypeptide expression in benign, borderline and malignant tumors , 1997, International journal of cancer.

[27]  J Downward,et al.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. , 1997, Trends in biochemical sciences.

[28]  S. Oldham,et al.  A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[29]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[30]  J. Mier,et al.  Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts. , 1997, Molecular biology of the cell.

[31]  M. Szyf,et al.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Baylin,et al.  New 5′ Regions of the Murine and Human Genes for DNA (Cytosine-5)-methyltransferase* , 1996, The Journal of Biological Chemistry.

[33]  J. Yokota,et al.  Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. , 1996, Cancer research.

[34]  D. Helfman,et al.  Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Kantoff,et al.  Two differentially expressed genes in normal human prostate tissue and in carcinoma. , 1996, Cancer research.

[36]  H. S. Lee,et al.  Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. , 1996, Oncogene.

[37]  S. Baylin,et al.  De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase , 1996, Molecular and cellular biology.

[38]  S. Oldham,et al.  Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Der,et al.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Okayama,et al.  Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. , 1996, Oncogene.

[41]  C. Der,et al.  Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.

[42]  M. Karin,et al.  Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.

[43]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[44]  M. Szyf,et al.  Ras Induces a General DNA Demethylation Activity in Mouse Embryonal P19 Cells (*) , 1995, The Journal of Biological Chemistry.

[45]  M. Szyf,et al.  Regulation of DNA methylation by the Ras signaling pathway , 1995, The Journal of Biological Chemistry.

[46]  M. Szyf,et al.  Regulation of the DNA Methyltransferase by the Ras-AP-1 Signaling Pathway (*) , 1995, The Journal of Biological Chemistry.

[47]  A. Masuda,et al.  Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA. , 1994, Cancer letters.

[48]  C. Der,et al.  Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras , 1994, Molecular and cellular biology.

[49]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[50]  R. Fuldner,et al.  Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA. , 1994, European journal of biochemistry.

[51]  D. Helfman,et al.  Functional properties of non-muscle tropomyosin isoforms. , 1994, Current opinion in cell biology.

[52]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[53]  R. Fuldner,et al.  Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Shirasawa,et al.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. , 1993, Science.

[55]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[56]  W. Stafford,et al.  Preferential assembly of the tropomyosin heterodimer: equilibrium studies. , 1991, Biochemistry.

[57]  P. Graceffa,et al.  Smooth muscle tropomyosin coiled-coil dimers. Subunit composition, assembly, and end-to-end interaction. , 1991, The Journal of biological chemistry.

[58]  S. Sakiyama,et al.  Suppression of synthesis of tropomyosin isoform 2 in metastatic v-Ha-ras-transformed NIH3T3 cells. , 1988, Biochemical and biophysical research communications.

[59]  S. Sakiyama,et al.  Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells , 1988, Molecular and cellular biology.

[60]  D. Salomon,et al.  Suppression of synthesis and utilization of tropomyosin in mouse and rat fibroblasts by transforming growth factor alpha: a pathway in oncogene action. , 1987, Cancer research.

[61]  Peter A. Jones.  Altering gene expression with 5-azacytidine , 1985, Cell.

[62]  F. Matsumura,et al.  Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. , 1983, The Journal of biological chemistry.

[63]  H. Weintraub,et al.  Tropomyosin is decreased in transformed cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[64]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[65]  E. Holborow,et al.  Contractile proteins in human cancer cells. Immunofluorescent and electron microscopic study. , 1976, The American journal of pathology.

[66]  S. Powers,et al.  Identification of Ras-regulated genes by representational difference analysis. , 2001, Methods in enzymology.

[67]  C. Deng,et al.  Role of the ras-MAPK Signaling Pathway in the DNA Methyltransferase Response to DNA Hypomethylation , 1998, Biological chemistry.

[68]  C. Marshall.  Ras effectors. , 1996, Current opinion in cell biology.

[69]  E Button,et al.  Actin, its associated proteins and metastasis. , 1995, Cell motility and the cytoskeleton.

[70]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[71]  P. Wirth,et al.  Two‐dimensional electrophoretic analysis of transformation‐sensitive polypeptides during chemically, spontaneously, and oncogene‐induced transformation of rat liver epithelial cells , 1992, Electrophoresis.